Tc Biopharm (holdings) PLC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
TC BioPharm reports recurring losses and expresses substantial doubt about its ability to continue as a going concern, despite advancing its GD-T cell therapies.